help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karlsson, M. K.
Right arrow Articles by Seeman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karlsson, M. K.
Right arrow Articles by Seeman, E.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Eating Disorders
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 9 3177-3182
Copyright © 2000 by The Endocrine Society


Original Studies

Bone Size and Volumetric Density in Women with Anorexia Nervosa Receiving Estrogen Replacement Therapy and in Women Recovered from Anorexia Nervosa

Magnus K. Karlsson1, Susan J. Weigall, Yunbo Duan and Ego Seeman

Department of Endocrinology, Austin and Repatriation Medical Center, and Department of Psychiatry, Royal Melbourne Hospital (S.J.W.), University of Melbourne, Melbourne 3084, Australia

Address all correspondence and requests for reprints to: Ego Seeman, M.D., Department of Endocrinology, Austin and Repatriation Medical Center, Heidelberg, Melbourne 3084, Australia. E-mail: ego{at}austin.unimelb.edu.au

Anorexia nervosa is associated with bone loss during adulthood, but may also delay skeletal growth and mineral accrual during growth. We asked the following questions. 1) Is anorexia nervosa associated with reduced bone size and reduced volumetric bone mineral density (vBMD)? 2) Is estrogen replacement therapy (ERT) or recovery from anorexia nervosa associated with normal bone size and vBMD?

Using dual-energy x-ray absorptiometry, we measured bone size and vBMD of the third lumbar vertebra and femoral neck in a cross-sectional study of 161 female patients: 77 with untreated anorexia nervosa, 58 with anorexia nervosa receiving ERT, 26 recovered from anorexia nervosa, and 205 healthy age-matched controls. Results were expressed as the SD or z-score (mean ± SEM).

Deficits in vertebral body and femoral neck width in untreated women were -1.0 ± 0.1 and -0.3 ± 0.1 SD (P < 0.001 and P < 0.05, respectively). Deficits in bone width were less in the ERT-treated women than in untreated women at the vertebral body (-0.6 ± 0.1 SD; P < 0.001), but not at the femoral neck (-0.4 ± 0.2 SD; P < 0.05). There were no significant deficits in vertebral body and femoral neck width in recovered women (both -0.3 ± 0.2 SD; P = NS). In untreated women, vertebral and femoral neck vBMD were -1.6 ± 0.1 and -1.1 ± 0.1 SD, respectively (both P < 0.001), less severely reduced in ERT-treated women (-1.2 ± 0.2 and -0.6 ± 0.2 SD, respectively; both P < 0.001), and least reduced in recovered women (-0.6 ± 0.1 and -0.5 ± 0.2 SD; P < 0.01 and P < 0.05, respectively). After adjusting for differences in fat and lean mass, vertebral body and femoral neck width were no longer reduced in untreated, ERT-treated, and recovered women. Adjustment for body composition had little effect on group difference in vBMD.

Bone fragility in anorexia nervosa is due to reduced bone size and reduced vBMD. Although causality cannot be inferred in cross- sectional studies, the data are consistent with the view that malnutrition may contribute to reduced bone size, whereas estrogen deficiency may reduce vBMD. The use of ERT early in disease is a reasonable component of management if the chance of recovery appears remote.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
B. Galusca, M. Zouch, N. Germain, C. Bossu, D. Frere, F. Lang, M.-H. Lafage-Proust, T. Thomas, L. Vico, and B. Estour
Constitutional Thinness: Unusual Human Phenotype of Low Bone Quality
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 110 - 117.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
S L Liu and C M Lebrun
Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review
Br. J. Sports Med., January 1, 2006; 40(1): 11 - 24.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. N. Roemmich, P. A. Clark, C. S. Mantzoros, C. M. Gurgol, A. Weltman, and A. D. Rogol
Relationship of Leptin to Bone Mineralization in Children and Adolescents
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 599 - 604.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Zipfel, M. J. Seibel, B. Lowe, P. J. Beumont, C. Kasperk, and W. Herzog
Osteoporosis in Eating Disorders: A Follow-Up Study of Patients with Anorexia and Bulimia Nervosa
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5227 - 5233.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Burguera, L. C. Hofbauer, T. Thomas, F. Gori, G. L. Evans, S. Khosla, B. L. Riggs, and R. T. Turner
Leptin Reduces Ovariectomy-Induced Bone Loss in Rats
Endocrinology, August 1, 2001; 142(8): 3546 - 3553.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society